182 related articles for article (PubMed ID: 11439168)
1. Structural analysis of TCRalpha and beta chains from human T-Cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70 kDa: TCR complementarity determining region 3 usage appears highly conserved.
Talken BL; Bailey CW; Reardon SL; Caldwell CW; Hoffman RW
Scand J Immunol; 2001; 54(1-2):204-10. PubMed ID: 11439168
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease.
Talken BL; Holyst MM; Lee DR; Hoffman RW
Arthritis Rheum; 1999 Apr; 42(4):703-9. PubMed ID: 10211884
[TBL] [Abstract][Full Text] [Related]
3. Human T cell clones reactive against U-small nuclear ribonucleoprotein autoantigens from connective tissue disease patients and healthy individuals.
Hoffman RW; Takeda Y; Sharp GC; Lee DR; Hill DL; Kaneoka H; Caldwell CW
J Immunol; 1993 Dec; 151(11):6460-9. PubMed ID: 8245479
[TBL] [Abstract][Full Text] [Related]
4. Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens.
De Silva-Udawatta M; Kumar SR; Greidinger EL; Hoffman RW
J Immunol; 2004 Mar; 172(6):3940-7. PubMed ID: 15004202
[TBL] [Abstract][Full Text] [Related]
5. Analysis of T cell receptors specific for U1-70kD small nuclear ribonucleoprotein autoantigen: the alpha chain complementarity determining region three is highly conserved among connective tissue disease patients.
Talken BL; Lee DR; Caldwell CW; Quinn TP; Schäfermeyer KR; Hoffman RW
Hum Immunol; 1999 Mar; 60(3):200-8. PubMed ID: 10321956
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease.
Greidinger EL; Zang YJ; Jaimes K; Martinez L; Nassiri M; Hoffman RW
J Immunol; 2008 Jun; 180(12):8444-54. PubMed ID: 18523312
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
[TBL] [Abstract][Full Text] [Related]
8. Immunization of mice with purified U1 small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies.
Reuter R; Lührmann R
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8689-93. PubMed ID: 2430297
[TBL] [Abstract][Full Text] [Related]
9. T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus.
Talken BL; Schäfermeyer KR; Bailey CW; Lee DR; Hoffman RW
J Immunol; 2001 Jul; 167(1):562-8. PubMed ID: 11418695
[TBL] [Abstract][Full Text] [Related]
10. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera.
Hirakata M; Craft J; Hardin JA
J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease.
Holyst MM; Hill DL; Hoch SO; Hoffman RW
Arthritis Rheum; 1997 Aug; 40(8):1493-503. PubMed ID: 9259431
[TBL] [Abstract][Full Text] [Related]
12. Anti-Sm and anti-RNP antibodies.
Migliorini P; Baldini C; Rocchi V; Bombardieri S
Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
14. T cells in the pathogenesis of systemic lupus erythematosus.
Hoffman RW
Front Biosci; 2001 Oct; 6():D1369-78. PubMed ID: 11578962
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.
Degen WG; Pieffers M; Welin-Henriksson E; van den Hoogen FH; van Venrooij WJ; Raats JM
Eur J Immunol; 2000 Oct; 30(10):3029-38. PubMed ID: 11069087
[TBL] [Abstract][Full Text] [Related]
16. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins.
Satoh M; Richards HB; Hamilton KJ; Reeves WH
J Immunol; 1997 May; 158(10):5017-25. PubMed ID: 9144522
[TBL] [Abstract][Full Text] [Related]
17. Autoantigenic epitopes of the B polypeptide of Sm small nuclear RNP particles. Identification of regions accessible only within the U1 small nuclear RNP.
Ohosone Y; Mimori T; Fujii T; Akizuki M; Matsuoka Y; Irimajiri S; Hardin JA; Craft J; Homma M
Arthritis Rheum; 1992 Aug; 35(8):960-6. PubMed ID: 1379432
[TBL] [Abstract][Full Text] [Related]
18. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients.
Okubo M; Yamamoto K; Kato T; Matsuura N; Nishimaki T; Kasukawa R; Ito K; Mizushima Y; Nishioka K
J Immunol; 1993 Jul; 151(2):1108-15. PubMed ID: 7687615
[TBL] [Abstract][Full Text] [Related]
19. Influence of antigen organization on the development of lupus autoantibodies.
Fatenejad S; Bennett M; Moslehi J; Craft J
Arthritis Rheum; 1998 Apr; 41(4):603-12. PubMed ID: 9550469
[TBL] [Abstract][Full Text] [Related]
20. B cell epitope on the U1 snRNP-C autoantigen contains a sequence similar to that of the herpes simplex virus protein.
Misaki Y; Yamamoto K; Yanagi K; Miura H; Ichijo H; Kato T; Mato T; Welling-Wester S; Nishioka K; Ito K
Eur J Immunol; 1993 May; 23(5):1064-71. PubMed ID: 7682956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]